- Home
- CAPR vs BCAL Comparison
CAPR vs BCAL Comparison
Compare CAPR & BCAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- BCAL
- Stock Information
- Founded
- CAPR 2005
- BCAL 2001
- Country
- CAPR United States
- BCAL United States
- Employees
- CAPR N/A
- BCAL N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- BCAL Major Banks
- Sector
- CAPR Health Care
- BCAL Finance
- Exchange
- CAPR Nasdaq
- BCAL Nasdaq
- Market Cap
- CAPR 578.4M
- BCAL 503.4M
- IPO Year
- CAPR N/A
- BCAL N/A
- Fundamental
- Price
- CAPR $14.06
- BCAL $15.20
- Analyst Decision
- CAPR Strong Buy
- BCAL
- Analyst Count
- CAPR 7
- BCAL 0
- Target Price
- CAPR $39.29
- BCAL N/A
- AVG Volume (30 Days)
- CAPR 1.1M
- BCAL 68.4K
- Earning Date
- CAPR 02-27-2025
- BCAL 01-28-2025
- Dividend Yield
- CAPR N/A
- BCAL N/A
- EPS Growth
- CAPR N/A
- BCAL N/A
- EPS
- CAPR N/A
- BCAL N/A
- Revenue
- CAPR $23,228,045.00
- BCAL $78,307,000.00
- Revenue This Year
- CAPR N/A
- BCAL N/A
- Revenue Next Year
- CAPR $74.85
- BCAL $48.22
- P/E Ratio
- CAPR N/A
- BCAL N/A
- Revenue Growth
- CAPR 65.33
- BCAL N/A
- 52 Week Low
- CAPR $3.52
- BCAL $12.30
- 52 Week High
- CAPR $23.40
- BCAL $18.49
- Technical
- Relative Strength Index (RSI)
- CAPR 48.54
- BCAL 32.66
- Support Level
- CAPR $12.31
- BCAL $15.05
- Resistance Level
- CAPR $16.17
- BCAL $15.79
- Average True Range (ATR)
- CAPR 0.82
- BCAL 0.48
- MACD
- CAPR 0.11
- BCAL -0.08
- Stochastic Oscillator
- CAPR 45.34
- BCAL 21.93
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through strong partnerships with its clients.